These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18972446)

  • 21. Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase?
    Zhu Z; Wilson AT; Luxon BA; Brown KE; Mathahs MM; Bandyopadhyay S; McCaffrey AP; Schmidt WN
    Hepatology; 2010 Dec; 52(6):1897-905. PubMed ID: 21105106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.
    Hou WH; Rossi L; Shan Y; Zheng JY; Lambrecht RW; Bonkovsky HL
    World J Gastroenterol; 2009 Sep; 15(36):4499-510. PubMed ID: 19777608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
    Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
    Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
    Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
    Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice.
    Nakagawa S; Umehara T; Matsuda C; Kuge S; Sudoh M; Kohara M
    Biochem Biophys Res Commun; 2007 Feb; 353(4):882-8. PubMed ID: 17196931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HCV proteins increase expression of heme oxygenase-1 (HO-1) and decrease expression of Bach1 in human hepatoma cells.
    Ghaziani T; Shan Y; Lambrecht RW; Donohue SE; Pietschmann T; Bartenschlager R; Bonkovsky HL
    J Hepatol; 2006 Jul; 45(1):5-12. PubMed ID: 16530877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity.
    Miura K; Taura K; Kodama Y; Schnabl B; Brenner DA
    Hepatology; 2008 Nov; 48(5):1420-9. PubMed ID: 18671304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses.
    Abdalla MY; Ahmad IM; Spitz DR; Schmidt WN; Britigan BE
    J Med Virol; 2005 Aug; 76(4):489-97. PubMed ID: 15977232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced heme oxygenase-1 expression in steatotic livers infected with hepatitis C virus.
    Abdalla MY; Mathahs MM; Ahmad IM
    Eur J Intern Med; 2012 Oct; 23(7):649-55. PubMed ID: 22939811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1).
    Miyamoto M; Kato T; Date T; Mizokami M; Wakita T
    Intervirology; 2006; 49(1-2):37-43. PubMed ID: 16166787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subversion of the Heme Oxygenase-1 Antiviral Activity by Zika Virus.
    El Kalamouni C; Frumence E; Bos S; Turpin J; Nativel B; Harrabi W; Wilkinson DA; Meilhac O; Gadea G; Desprès P; Krejbich-Trotot P; Viranaïcken W
    Viruses; 2018 Dec; 11(1):. PubMed ID: 30577437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
    Kasai D; Adachi T; Deng L; Nagano-Fujii M; Sada K; Ikeda M; Kato N; Ide YH; Shoji I; Hotta H
    J Hepatol; 2009 May; 50(5):883-94. PubMed ID: 19303158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of dual specificity phosphatase I expression inhibits hepatitis C virus replication.
    Choi JE; Kwon JH; Kim JH; Hur W; Sung PS; Choi SW; Yoon SK
    PLoS One; 2015; 10(3):e0119172. PubMed ID: 25798824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system.
    Chung RT; He W; Saquib A; Contreras AM; Xavier RJ; Chawla A; Wang TC; Schmidt EV
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9847-52. PubMed ID: 11493707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.
    Saito K; Shirasago Y; Suzuki T; Aizaki H; Hanada K; Wakita T; Nishijima M; Fukasawa M
    J Virol; 2015 Feb; 89(4):2220-32. PubMed ID: 25473062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-let-7c suppresses hepatitis C virus replication by targeting Bach1 for induction of haem oxygenase-1 expression.
    Chen WC; Wei CK; Lee JC
    J Viral Hepat; 2019 Jun; 26(6):655-665. PubMed ID: 30706605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of short RNA structural analogues against hepatitis C virus genotypes 2, 3 and 4 in replicon cells.
    Elshaffei IM; Gupta N; Wu CH; Wu DC; Hammad LN; Abo-Elmatty DM; Mesbah NM; Wu GY
    J Dig Dis; 2015 Aug; 16(8):449-55. PubMed ID: 25873200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection.
    Sarrazin C; Mihm U; Herrmann E; Welsch C; Albrecht M; Sarrazin U; Traver S; Lengauer T; Zeuzem S
    J Infect Dis; 2005 Nov; 192(10):1710-9. PubMed ID: 16235168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.